Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice
about
Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapyNeutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor modelOverview of current immunotherapeutic strategies for gliomaLiver-specific alpha 2 interferon gene expression results in protection from induced hepatitis.Experimental approaches for the treatment of malignant gliomas.Gene therapy for high grade gliomas.Foot-and-mouth disease.Gene therapy for malignant glioma.Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host responseNew approaches to rapidly control foot-and-mouth disease outbreaks.Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.Gene therapy in the treatment of heart failure.Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas.AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical modelsSite-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b.Strategies in gene therapy for glioblastoma.A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response.Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma: implications for cancer growth.Aberrant DNA methylation of miR-219 promoter in long-term night shiftworkers.Amprenavir inhibits the migration in human hepatocarcinoma cell and the growth of xenografts.Interferon-β-armed oncolytic adenovirus induces both apoptosis and necroptosis in cancer cells.Interferon-β lipofection II. Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-β gene transfer to human tumor cells.Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease.Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs.Gene therapy of ovarian cancer with IFN-alpha-producing fibroblasts: comparison of constitutive and inducible vectors.Gene- and viral-based therapies for brain tumorsAnti-colorectal cancer effect of interleukin-2 and interferon-β fusion gene driven by carcinoembryonic antigen promoter.Adenovirus delivery provides extended interferon-alpha exposure and augments treatment of metastatic carcinoma.Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide.Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.Long-term high-dose interferon-alpha therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic mice.Anti-inflammatory action of type I interferons deduced from mice expressing interferon beta.Calcineurin subunit B upregulates β-interferon production by phosphorylation of interferon regulatory factor 3 via Toll-like receptor 4.
P2860
Q24605512-6D31E6CB-68A4-4B77-A098-188B2312A4C6Q24612339-6EF0640B-21C7-4A8A-A08E-4D17E5BE39B3Q26776345-D129AC79-6893-4CE8-9DC1-D0DB3A1AF9F1Q33804926-BD75607E-0BE9-4153-BD31-C4C77F63F664Q34127138-2DCD5A65-F773-4750-AFA3-F2A2DC8EF9BBQ34452062-7B16D1D8-CD39-4AC5-808B-3797385ADECFQ34547126-E7D6C783-DA0D-420A-91EE-83D02DDD7C56Q35673628-EC3E7C43-D6F4-40E4-8425-96C46214ECEBQ35786848-3B512411-3140-4787-B93F-8E82081F806DQ35917287-400E3894-DDAF-415B-A4F8-8678CF2AC7F8Q36167296-5C2F0FCC-9FA6-4329-BD4A-2C555EF0245BQ36786243-8A9C41A4-FBFF-4CF2-8F36-89F4215A169EQ36866472-23368F2A-07DA-4F49-B1CD-23F2CA2B56D2Q37088489-159D51BE-E457-4755-8F13-A23E079F4203Q37301637-D868E015-D1F9-443C-AA04-B5AE0CDBC3D8Q37404242-0E7AC56B-DDB0-4B9E-9FC2-7E67F40A6A23Q37420576-A24481F1-6EBE-4DFC-89DF-32AAF30FA6D5Q38357901-61CAC42C-4C16-43AA-8688-8DFBED3F45ADQ38517215-00F8FB73-7EDA-4FB2-85AB-8ADD466B9F51Q39132762-97CCA315-EF58-418C-B146-EA57319D3E12Q39298919-23F4AE93-1975-4CD1-A23F-A13FF54F0C2AQ39306638-F3505169-BC19-4171-A1E0-3D1EDDB4ED6AQ39354078-33481106-4320-4373-B509-7CB2E9382E14Q39699303-B1BC5575-DE5D-4EBF-B95C-C7494327ACBFQ39963975-4095792C-B16D-4C68-AF0D-ECAB089A8AA0Q40309654-84475373-5531-4B17-AC8B-88B328FB75F0Q42135456-AE266ED5-5266-4DB6-8F92-21D36F86AF63Q42574280-5819E729-3242-4C9B-BDAE-2C67055244C0Q43412741-25A7F383-8AC2-4571-9476-EA4A3E53CE00Q44194187-DD9E0C8B-F279-4CC7-8D56-992F3566832DQ44393120-2DF5673C-505A-48A7-99FC-48A1EEFEF408Q44796636-F08BD6E5-3113-4665-AB18-959F9EDDB150Q45868391-B135D786-001B-4F5A-B8C8-ABE21DB704E2Q54337036-72AD5ADC-94A2-4081-B979-999365930328
P2860
Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Interferon-beta gene therapy i ...... umors in immune-deficient mice
@ast
Interferon-beta gene therapy i ...... umors in immune-deficient mice
@en
type
label
Interferon-beta gene therapy i ...... umors in immune-deficient mice
@ast
Interferon-beta gene therapy i ...... umors in immune-deficient mice
@en
prefLabel
Interferon-beta gene therapy i ...... umors in immune-deficient mice
@ast
Interferon-beta gene therapy i ...... umors in immune-deficient mice
@en
P2093
P2860
P356
P1476
Interferon-beta gene therapy i ...... umors in immune-deficient mice
@en
P2093
J M Wilson
P2860
P304
14411-14416
P356
10.1073/PNAS.95.24.14411
P407
P577
1998-11-01T00:00:00Z